|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L: The Correlation between EGFR Gene
Mutation and serum tumor markers in lung adenocarcinoma
(unpublished master's thesis)Zhengzhou University. Zhengzhou: 2014,
View Article : Google Scholar
|
|
4
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Lu Y, Wu J, Gao M, Wang A and Xu
B: Beta-elemene inhibits melanoma growth and metastasis via
suppressing vascular endothelial growth factor-mediated
angiogenesis. Cancer Chemother Pharmacol. 67:799–808. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang H, Ma S and Feng J: In vitro study
of radiosensitization by beta-Elemene in A549 cell line from
adenocarcinoma of lung. Chinese-German J Clin Oncol. 8:12–15. 2009.
View Article : Google Scholar
|
|
7
|
Li QQ, Wang G, Reed E, Huang L and Cuff
CF: Evaluation of cisplatin in combination with β-elemene as a
regimen for prostate cancer chemotherapy. Basic Clin Pharmacol
Toxicol. 107:868–876. 2010.PubMed/NCBI
|
|
8
|
Li QQ, Wang G, Zhang M, Cuff CF, Huang L
and Reed E: beta-Elemene, a novel plant-derived antineoplastic
agent, increases cisplatin chemosensitivity of lung tumor cells by
triggering apoptosis. Oncol Rep. 22:161–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Wang G, Zhao J, Ding H, Cunningham
C, Chen F, Flynn DC, Reed E and Li QQ: Antiproliferative effect of
beta-elemene in chemoresistant ovarian carcinoma cells is mediated
through arrest of the cell cycle at the G2-M phase. Cell Mol Life
Sci. 62:894–904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang G, Li X, Huang F, Zhao J, Ding H,
Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect
of beta-elemene in non-small-cell lung cancer cells is mediated via
induction of cell cycle arrest and apoptotic cell death. Cell Mol
Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yao CC, Tu YR, Jiang J, Ye SF, Du HX and
Zhang Y: β-elemene reverses the drug resistance of lung cancer
A549/DDP cells via the mitochondrial apoptosis pathway. Oncol Rep.
31:2131–2138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells
depends on p38 MAPK activation. Cancer Lett. 264:127–134. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Z, Wang R, Xu L, Xie S, Dong J and Jing
Y: β-Elemene piperazine derivatives induce apoptosis in human
leukemia cells through downregulation of c-FLIP and generation of
ROS. PLoS One. 6:e158432011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao J, Li QQ, Zou B, Wang G, Li X, Kim
JE, Cuff CF, Huang L, Reed E and Gardner K: In vitro
combination characterization of the new anticancer plant drug
β-elemene with taxanes against human lung carcinoma. Int J Oncol.
31:241–252. 2007.PubMed/NCBI
|
|
15
|
Zhu T, Xu Y, Dong B, Zhang J, Wei Z, Xu Y
and Yao Y: β-elemene inhibits proliferation of human glioblastoma
cells through the activation of glia maturation factor β and
induces sensitization to cisplatin. Oncol Rep. 26:405–413.
2011.PubMed/NCBI
|
|
16
|
Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo
A and Wang W: Assessing the quality of RCTs on the effect of
beta-elemene, one ingredient of a Chinese herb, against malignant
tumors. Contemp Clin Trials. 27:70–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du XS, Yu J, Li JY, Liu A, Yang SY and
Wang YL: Effect of β-elemene on the proliferation and apoptosis of
human lung cancer A549 and H460 cells. Shaanxi Med J. 9:1107–1108.
2015.(In Chinese).
|
|
19
|
Gao HJ and Qin HF: Elemene for non-small
cell lung cancer. Xiandai Shengwu Yixue Jinzhan. 21:4149–4151.
2010.
|
|
20
|
Li YJ, Yu J and Miao Y: Effects of
β-elemene on the proliferation of lung adenocarcinoma cells.
Shaanxi Med J. 2:136–138+164. 2016.
|
|
21
|
Zhou Q, Effati R, Talvinen K, Pospiech H,
Syväoja JE and Collan Y: Genomic changes of the 55 kDa subunit of
DNA polymerase epsilon in human breast cancer. Cancer Genomics
Proteomics. 5:287–292. 2008.PubMed/NCBI
|
|
22
|
Loeb LA and Monnat RJ Jr: DNA polymerases
and human disease. Nat Rev Genet. 9:594–604. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chubb D, Broderick P, Dobbins SE, Frampton
M, Kinnersley B, Penegar S, Price A, Ma YP, Sherborne AL, Palles C,
et al: Rare disruptive mutations and their contribution to the
heritable risk of colorectal cancer. Nat Commun. 7:118832016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hartmann E, Fernàndez V, Moreno V, Valls
J, Hernández L, Bosch F, Abrisqueta P, Klapper W, Dreyling M,
Hoster E, et al: Five-gene model to predict survival in mantle-cell
lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.
J Clin Oncol. 26:4966–4972. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu D: Sine oculis homeobox homolog1
promotes cell proliferation and metastasis of cervical cancer
(doctoral thesis)Huazhong University of Science and Technology.
Wuhan: 2014, (In Chinese). View Article : Google Scholar
|
|
26
|
Zekri AR, Hassan ZK, Bahnassy AA, Khaled
HM, El-Rouby MN, Haggag RM and Abu-Taleb FM: Differentially
expressed genes in metastatic advanced Egyptian bladder cancer.
Asian Pac J Cancer Prev. 16:3543–3549. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Frugoni F, Dobbs K, Felgentreff K,
Aldhekri H, Al Saud BK, Arnaout R, Ali AA, Abhyankar A, Alroqi F,
Giliani S, et al: A novel mutation in the POLE2 gene causing
combined immunodeficiency. J Allergy Clin Immunol. 137(635–638):
e12016.
|
|
28
|
Spier I, Holzapfel S, Altmüller J, Zhao B,
Horpaopan S, Vogt S, Chen S, Morak M, Raeder S, Kayser K, et al:
Frequency and phenotypic spectrum of germline mutations in
POLE and seven other polymerase genes in 266 patients with
colorectal adenomas and carcinomas. Int J Cancer. 137:320–331.
2015. View Article : Google Scholar : PubMed/NCBI
|
